Now, the scientists are testing the drugs on animals to see if they get the same results. If so, the treatment could be readily available since analogues of the specific compounds tested have already been studied clinically and they can be fast-tracked for public use.IIBR has been at the forefront of the fight against the novel coronavirus. Earlier this month, it filed patent requests for eight types of coronavirus antibodies that it has isolated and that will be used for the development of a future drug to treat COVID-19, the disease it causes. The institute also reported that it had successfully completed its coronavirus vaccine experiments on rodents and is moving on to test it on other animals before testing humans.